4-((2-Hydroxyethoxy)carbonyl)benzoic acid, 95%, 250mg

2,4-Dimethoxybenzoylacetonitrile, 95.0%, 1g

Methyl 6-bromo-1-methyl-1H-indazole-4-carboxylate, 98%, 500mg

2-{3-hydroxy-1H-cyclopenta[b]naphthalen-1-ylidene}propanedinitrile, 97%, 50mg

1-(tert-Butoxycarbonyl)-5,5-difluoropiperidine-3-carboxylic acid, 95.0%, 250mg

methyl 2-amino-6-propyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylate, 95.0%, 500mg

1-Isopropylpyrrolidine-2,3-dione, 98%, 2.5g

4-Butyl-4'-((4-butyl-2,6-difluorophenyl)ethynyl)-1,1'-biphenyl, 98%, 100mg

Nalpha-Tosyl-L-arginine Methyl Ester Hydrochloride>98.0%(T)1g

2-(2-Chloroethyl)-1h-1,3-benzodiazole hydrochloride, 95+%, 100mg

Frita reversible 10 ml, 4 (10 – 16 μm), 1 pieza

D-Aspartic acid, 1,4-bis(phenylmethyl) ester, hydrochloride (1:1), 97%, 100g

o-toluidina, mínimo 99,5 %, pa, 500 ml, envase de vidrio